Explore evidence

2.43 %2,43 % des enfants âgés de 5 à 9 ans présentant une hyper-parasitémie (≥200 000 parasites/μL) avaient un intervalle de confiance à 95 % de 1,35 à 3,52 %.

MalipaludismeHAL · Unilimdocument of 214 observations

12.82 %La prévalence du paludisme clinique chez les enfants de moins de 5 ans était de 12,82 %.

MalipaludismeHAL · Unilimdocument of 214 observations

6 %Chez les 198 patients du groupe Bougoula Hameau, 11 présentaient des gamétocytes de Plasmodium falciparum, soit 6 %.

MalipaludismeHAL · Unilimdocument of 62 observations

81.67 %SickleScan® had a sensitivity of 81.67% to detect sickle cell disease compared to high-performance liquid chromatography.

MalidrépanocytoseHAL · Unilimdocument of 103 observations

7 mérozoïtes/schizonteLe nombre moyen de mérozoïtes par schizonte était de sept.

MalipaludismeHAL · Unilimdocument of 214 observations

1.67 per_1000In 2023, the hospital fatality rate for malaria in Mali was 1.67 per 1000.

Malipaludismeobserved 2023HAL · Unilimdocument of 95 observations

3.05 %Elevated ALT was noted in 3.05% of treated malaria episodes.

Malipaludismepublished 2021Malaria journaleurope_pmcdocument of 14 observationsDOI 10.1186/s12936-021-03593-6

10 %The 2023 LLIN mass distribution campaign in Mali reduced malaria incidence by 10%.

Malipaludismeobserved 2023HAL · Unilimdocument of 95 observations

84.5 %In children who received RTS,S/AS01E vaccine in Burkina Faso and Mali, 84.5% showed a 2-fold increase in anti-CSP IgG antibody titres post-2019 as measured by GSK ELISA.

Burkina Faso · Malipaludismeobserved post-2019HAL · Unilimdocument of 105 observations

48.7 %The allelic frequency of the homozygote mutant variant of the CD209 gene promoter was 48.7% in Africans, 42.1% in African Americans, and 19.8% in Caucasians.

Maliinfectious diseasepublished 2015PeerJOpenAlexdocument of 9 observationsDOI 10.7717/peerj.799

99.69 %SickleScan® had a negative predictive value of 99.69% to detect sickle cell disease compared to high-performance liquid chromatography.

MalidrépanocytoseHAL · Unilimdocument of 103 observations

1 mutationL'analyse des gènes kelch d’isolats de P. malariae dans une étude de Gavin et al. (2017) a révélé une seule mutation non synonyme dans un seul isolat.

Malipaludismeobserved 2017HAL · Unilimdocument of 214 observations

41.51 %Une proportion de 41,51 % des porteurs de Plasmodium malariae présentaient une anémie (niveau d'hémoglobine < 11 g/dL), avec un intervalle de confiance à 95 % de 35,40 à 47,31 %.

MalianémieHAL · Unilimdocument of 214 observations

2.56 log10_copies/mLAt day 14, the median viral load of malaria cases treated with artemether-lumefantrine was 2.56 log10 copies/mL, compared to 2.86 log10 copies/mL in non-malaria comparisons.

Malicytomegalovirus (CMV)published 2016Journal of clinical virology : the official publication of the Pan American Society for Cleurope_pmcdocument of 6 observations

769,770,000 infectionsBy August 2023, COVID-19 had resulted in 769.77 million infections globally, with 6.95 million deaths.

MaliCOVID-19observed August 2023HAL · Unilimdocument of 88 observations

69,000 décèsEntre 2019 et 2020, l'augmentation des décès liés au paludisme a été de 69 000.

Malipaludismeobserved 2019-2020HAL · Unilimdocument of 214 observations

0.48 SIRThe mobile health teams intervention had a standardized incidence ratio (SIR) of 0.48 with 95% confidence interval [0.28; 0.82] (p = 0.01).

MalipaludismeHAL · Unilimdocument of 80 observations

2.1 %Chez les 95 patients du groupe Kollé, 2 présentaient des formes asexuées de Plasmodium ovale, soit 2,1 %.

MalipaludismeHAL · Unilimdocument of 62 observations

8.4 %The lowest intermittent preventive treatment in pregnancy (IPTp) coverage rate (8.4%) was observed in the health district of Tin-essako (Menaka region in the north) in the year 2019–2020.

Malipaludismeobserved 2019–2020HAL · Unilimdocument of 111 observations

34 %L'accès au traitement antipaludique était plus faible dans le bras SOC (120 sur 350, soit 34 % ; IC 95 % : 29–39 %) que dans le bras intervention (372 sur 495, soit 75 % ; IC 95 % : 71–79 %).

MalipaludismeHAL · Unilimdocument of 36 observations

29 joursYoung et Burgess ont rapporté une période pré-patente de P. malariae de 29 et 59 jours.

MalipaludismeHAL · Unilimdocument of 214 observations

313 per_1000_person-years_at_riskOver a 5-year period, the incidence of clinical malaria was 313 per 1000 person-years at risk in the seasonal malaria chemoprevention (SMC) alone group.

Malipaludismepublished 2024The Lancet. Infectious diseaseseurope_pmcdocument of 12 observationsDOI 10.1016/s1473-3099(23)00368-7

37 %In 2023, malaria accounted for a morbidity of 37% of cases in Mali.

Malipaludismeobserved 2023HAL · Unilimdocument of 95 observations

0.5 SIRThe extended seasonal malaria chemoprevention intervention had a standardized incidence ratio (SIR) of 0.5 with 95% confidence interval [0.33; 0.75] (p = 0.002).

MalipaludismeHAL · Unilimdocument of 80 observations

1.9 per_milleFor seasonal malaria chemoprevention (SMC), the reduction in malaria incidence was 1.9‰ in health districts with an adjusted coverage rate from 50.0 to 80.0%.

MalipaludismeHAL · Unilimdocument of 111 observations